Overview
ARA-290 Overview
ARA-290 is a synthetic peptide of 11 amino acids. Its sequence matches the water-facing surface of helix B in erythropoietin (EPO), and an N-terminal pyroglutamate caps the chain. In published research it also appears as cibinetide and pHBSP.
Receptor selectivity is what sets ARA-290 apart. In laboratory models it binds the heterocomplex formed by the EPO receptor and the beta common receptor (CD131). It does not bind the classical EPO receptor homodimer. This lets researchers study EPO receptor signaling separately from the erythropoietic pathway. In vitro and preclinical studies have examined four areas: TRPV1 channel activity in cultured sensory neurons, IL-6, IL-12, and TNF-α secretion in macrophage cultures, NF-κB and PI3K/Akt signaling, and endothelial cell viability under oxidative stress.
Each lot is made by solid-phase peptide synthesis, third-party tested, and supplied with a Certificate of Analysis.
| Sequence | pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser (pEQLERALNSS) |
|---|---|
| Sequence length | 11 amino acids |
| Also known as | Cibinetide, ARA 290, ARA290, pHBSP (pyroglutamate helix B surface peptide) |
| Molecular formula | C51H84N16O21 |
| Molecular weight | 1257.3 g/mol |
| CAS number | 1208243-50-8 |
| PubChem CID | 91810664 |
| Form | Lyophilized powder |
| Purity | >99% by HPLC, per COA |
| Storage | -20°C, sealed and protected from light |
Certificate of Analysis
| Date | Lot | Certificate |
|---|---|---|
| ARA-290 [size]mgFeb 4, 2026 | 011652-20260121001 | View COA |